Tesorx Pharma, LLC
Records under this name other than the patents Tesorx Pharma, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.
Showing 1 to 5 of 5 · Back to Tesorx Pharma, LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,229,602 | Formulations for treating bladder cancer Lapsed on the fee record Ended Jan 25, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jan 25, 2026 | From the USPTO record |
| US 9,445,995 | Proliposomal testosterone formulations Lapsed on the fee record Ended Sep 20, 2024 · From the USPTO record | Lapsed on the fee record | Ended Sep 20, 2024 | From the USPTO record |
| US 8,957,053 | Proliposomal testosterone formulations Formerly held Lapsed on the fee record Ended Feb 17, 2023 · From the USPTO record | Lapsed on the fee record | Ended Feb 17, 2023 | From the USPTO record |
| US 9,844,557 | Proliposomal testosterone formulations Lapsed on the fee record Ended Dec 19, 2021 · From the USPTO record | Lapsed on the fee record | Ended Dec 19, 2021 | From the USPTO record |
| US 9,623,033 | Proliposomal testosterone formulations Lapsed on the fee record Ended Apr 18, 2021 · From the USPTO record | Lapsed on the fee record | Ended Apr 18, 2021 | From the USPTO record |